In 2019, it was revealed for the first time that the iron metabolism regulatory molecule Hemojuvelin (HJV or HFE2) is a protective gene that inhibits the occurrence of Duchenne muscular dystrophy and senile muscle atrophy. The gene discussed is HJV; the disease is Duchenne muscular dystrophy.